Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 464 of 1,261
  1. US 10456461

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  2. US 10456471

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  3. US 10456412

    Lipid extraction processes

    AKER BIOMARINE ANTARCTIC AS · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  4. US 10456408

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    ESSENTIALIS, INC. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  5. US 10456380

    Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonists

    Cumberland Pharmaceuticals Inc. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  6. US 10456404

    Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  7. US 10456392

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  8. US 10456346

    Cosmetic formulations for topical applications containing erythropoietin-derived molecules

    ASC REGENITY LIMITED · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  9. US 10456340

    Liquid-impregnated nonwoven fabric which contains zinc oxide-containing cellulose fibers

    LENZING AKTIENGESELLSCHAFT · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  10. US 10455849

    Method for the preparation of a protein peptide, a protein peptide and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  11. US 10456292

    Compositions and methods relating to an occlusive polymer hydrogel

    Revolution Contraceptives LLC · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  12. US 10456333

    Dental adhesive

    KURARAY NORITAKE DENTAL INC. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  13. US 10457701

    Sialic acid analogs

    Ultragenyx Pharmaceutical Inc. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  14. US 10456406

    Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb

    VTV THERAPEUTICS LLC · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  15. US 10457745

    Anti-complement C1s antibodies

    Bioverativ USA Inc. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  16. US 10457726

    Antibody and antigen-binding fragment compositions targeting cell surface antigens in tumors and methods of use thereof

    UNIVERSITY OF CONNECTICUT · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  17. US 10457725

    Methods of treating skin cancer by administering a PD-1 inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  18. US 10457945

    UNA oligomers for therapeutics with prolonged stability

    ARCTURUS THERAPEUTICS, INC. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  19. US 10457676

    Capsazepine analogs for the treatment of cancer and other proliferative diseases

    The Board of Regents of the University of Texas System · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  20. US 10457662

    Substituted amides for treating and preventing cancer

    The Board of Regents of the University of Texas System · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  21. US 10456473

    Lipid compositions

    ARBUTUS BIOPHARMA CORPORATION · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  22. CA 3097087

    COMBINAISON COMPRENANT UN INHIBITEUR DE HDAC, UN INHIBITEUR DE LAG-3 ET UN INHIBITEUR DE PD-1 OU UN INHIBITEUR DE PD-L1 POUR LE TRAITEMENT DU CANCER

    4SC AG [DE] · Granted Oct 24, 2019 · Expires Oct 19, 2039

    granted
  23. US 10450285

    2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors

    University College Cardiff Consultants Limited · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted
  24. US 10449232

    Puma protein expression vector and use thereof in gene therapy

    The Regents of the University of California · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.